Riemann, D.; Schütte, W.; Turzer, S.; Seliger, B.; Möller, M.
High PD-L1/CD274 Expression of Monocytes and Blood Dendritic Cells Is a Risk Factor in Lung Cancer Patients Undergoing Treatment with PD1 Inhibitor Therapy. Cancers 2020, 12, 2966.
https://doi.org/10.3390/cancers12102966
AMA Style
Riemann D, Schütte W, Turzer S, Seliger B, Möller M.
High PD-L1/CD274 Expression of Monocytes and Blood Dendritic Cells Is a Risk Factor in Lung Cancer Patients Undergoing Treatment with PD1 Inhibitor Therapy. Cancers. 2020; 12(10):2966.
https://doi.org/10.3390/cancers12102966
Chicago/Turabian Style
Riemann, Dagmar, Wolfgang Schütte, Steffi Turzer, Barbara Seliger, and Miriam Möller.
2020. "High PD-L1/CD274 Expression of Monocytes and Blood Dendritic Cells Is a Risk Factor in Lung Cancer Patients Undergoing Treatment with PD1 Inhibitor Therapy" Cancers 12, no. 10: 2966.
https://doi.org/10.3390/cancers12102966
APA Style
Riemann, D., Schütte, W., Turzer, S., Seliger, B., & Möller, M.
(2020). High PD-L1/CD274 Expression of Monocytes and Blood Dendritic Cells Is a Risk Factor in Lung Cancer Patients Undergoing Treatment with PD1 Inhibitor Therapy. Cancers, 12(10), 2966.
https://doi.org/10.3390/cancers12102966